Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events
This update describes Mayo Clinic's study using patient-derived induced pluripotent stem cells to model adverse events associated with cance…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Study of ZG005 in Patients With Advanced Solid Tumors [Phase 2]
A Phase 2 clinical trial evaluating ZG005 in patients with advanced solid tumors is currently recruiting in China.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS [Phase 1, Phase 2]
Clinical trial update for SHR-A1904 evaluating safety, tolerability, pharmacokinetics, and efficacy in subjects with advanced solid tumors. …
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors [Phase 1]
Phase I study to evaluate safety, tolerability, pharmacokinetics, and efficacy of YL211 in patients with advanced solid tumors.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Imaging of Solid Tumors Using FAP-2286 [Phase 1]
Phase 1 clinical trial exploring imaging of solid tumors in adults using the FAP-2286 tracer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Impact of Immunotherapy on Vestibular Function, The Mayo Clinic Arizona Experience
A Mayo Clinic clinical trial update indicates ongoing enrollment by invitation to study the impact of immunotherapy on vestibular function i…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation [Phase 1]
Phase I first-in-human study evaluating GenSci128 in patients with solid tumors harboring a TP53 Y220C mutation; the trial is currently recr…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Special Drug Use-results Surveillance of Tafinlar/Mekinist
Clinical-trial update reporting ongoing surveillance of the dabrafenib/trametinib combination (Tafinlar/Mekinist) for BRAF V600E mutation-po…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 [Phase 1]
A Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics of the investigational compound PMC-309 in patients with …
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating Denikitug (GS-1811) alone or with Zimberelimab in adults with advanced solid tumors is currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update shows AP601 being studied in locally unresectable advanced or metastatic solid tumors, with recruitment ongoing. The sp…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: T Cell Inflamed Gene Expression Profiling Score-guided Anti PD-1 Therapy (Tislelizumab Monotherapy) for Refractory Solid Cancer Patients Unexposed to Immunotherapy [Phase 2]
Phase 2 trial evaluating tislelizumab monotherapy guided by a T cell inflamed gene expression profiling score for refractory solid tumors in…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Study of YL242 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of YL242 in advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: xDRIVE for Florida-based Cancer Patients [NA]
A Florida-based clinical trial for a cancer therapy named xDRIVE is currently recruiting, sponsored by First Ascent Biomedical Inc.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating TYK-01054 capsules in patients with advanced solid tumors, including malignant mesothelioma; the study…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations [Phase 1]
Phase 1 clinical trial evaluating autologous CD8+ and CD4+ T cells engineered with high-affinity KRASG12V-specific T cell receptors (FH-A11K…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Clinical Study of GO306 in Patients With Advanced Solid Tumors [Phase 1]
This document reports an ongoing Phase 1 study of GO306 in patients with advanced solid tumors. The trial is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating PT0253 in participants with KRAS G12D-mutated advanced solid tumors; study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors [NA]
A Mayo Clinic-sponsored study is evaluating educational tools to improve early advance care planning in adolescents and young adults with ad…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study to evaluate the safety of INCA33890 in participants with advanced or metastatic solid tumors is currently recruiting, sponso…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours) [Phase 1]
A Phase 1 trial evaluating different doses of BI 1703880 in combination with Ezabenlimab to assess tolerability in adults with advanced soli…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors [Phase 1]
Clinical trial update for a Phase 1 study evaluating the safety and pharmacokinetics of ADU-1805 in adults with advanced solid tumors; the s…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive [Phase 2]
Clinical trial update for INCB099280 in Phase 2 evaluating patients with select solid tumors who have not previously received immune checkpo…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study [Phase 1]
An Investigator Initiated Trial Phase 1 study is evaluating AT1019 in combination with SBRT and a PD-1 inhibitor for patients with advanced …
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Community-Based Physical Activity Intervention for Underserved Cancer Survivors [NA]
This clinical trial update describes a community-based physical activity intervention for underserved cancer survivors that is currently rec…